NORTILIDINE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	RACEMIC
Molecular Formula	C16H21NO2
Molecular Weight	259.3434
Optical Activity	( + / - )
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of NORTILIDINE

Structure Search

SMILES

CCOC(=O)[C@]1(CCC=C[C@@H]1NC)C2=CC=CC=C2

InChI

InChIKey=PDJZPNKVLDWEKI-GOEBONIOSA-N

InChI=1S/C16H21NO2/c1-3-19-15(18)16(13-9-5-4-6-10-13)12-8-7-11-14(16)17-2/h4-7,9-11,14,17H,3,8,12H2,1-2H3/t14-,16+/m0/s1

HIDE SMILES / InChI

Molecular Formula	C16H21NO2
Molecular Weight	259.3434
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Mon Mar 31 23:15:39 GMT 2025` Edited by `admin` on `Mon Mar 31 23:15:39 GMT 2025`
Record UNII	7145G6817J
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

NORTILIDINE

Common Name

English

1-PHENYL-1-TRANS-CARBETHOXY-2-METHYLAMINOCYCLOHEX-3-ENE

Preferred Name

English

3-CYCLOHEXENE-1-CARBOXYLIC ACID, 2-(METHYLAMINO)-1-PHENYL-, ETHYL ESTER, (1R,2S)-REL-

Systematic Name

English

3-CYCLOHEXENE-1-CARBOXYLIC ACID, 2-(METHYLAMINO)-1-PHENYL-, ETHYL ESTER, TRANS-

Common Name

English

3-CYCLOHEXENE-1-CARBOXYLIC ACID, 2-(METHYLAMINO)-1-PHENYL-, ETHYL ESTER, TRANS-(±)-

Systematic Name

English

Classification Tree Code System Code

WIKIPEDIA

Designer-drugs-Nortilidine

Created by admin on Mon Mar 31 23:15:39 GMT 2025 , Edited by admin on Mon Mar 31 23:15:39 GMT 2025

Code System Code Type Description

CAS

38677-94-0

Created by admin on Mon Mar 31 23:15:39 GMT 2025 , Edited by admin on Mon Mar 31 23:15:39 GMT 2025

PRIMARY

PUBCHEM

162321

Created by admin on Mon Mar 31 23:15:39 GMT 2025 , Edited by admin on Mon Mar 31 23:15:39 GMT 2025

PRIMARY

CHEBI

77829

Created by admin on Mon Mar 31 23:15:39 GMT 2025 , Edited by admin on Mon Mar 31 23:15:39 GMT 2025

PRIMARY

FDA UNII

7145G6817J

Created by admin on Mon Mar 31 23:15:39 GMT 2025 , Edited by admin on Mon Mar 31 23:15:39 GMT 2025

PRIMARY

EPA CompTox

DTXSID10191973

Created by admin on Mon Mar 31 23:15:39 GMT 2025 , Edited by admin on Mon Mar 31 23:15:39 GMT 2025

PRIMARY

WIKIPEDIA

Nortilidine

Created by admin on Mon Mar 31 23:15:39 GMT 2025 , Edited by admin on Mon Mar 31 23:15:39 GMT 2025

PRIMARY

Related Record Type Details


					1PE72K8X46

MU-TYPE OPIOID RECEPTOR

TARGET -> AGONIST

Comments:

Inhibition of forskolin-induced cAMP accumulation.

Qualification:

IC50

Amount:


					PUO0521HZV

CYTOCHROME P450 3A4

METABOLIC ENZYME -> SUBSTRATE

Amount:


					081I12ZA58

CYTOCHROME P450 2C19

METABOLIC ENZYME -> SUBSTRATE

Amount:

Related Record Type Details


					58NDD17NUF

METABOLITE LESS ACTIVE -> PARENT

Comments:

Shows six times less affinity to Mu-receptor than nortilidine

Amount:


					GY33N31E9Y

TILIDINE

PRODRUG -> METABOLITE ACTIVE

Comments:

After oral intake tilidine is completely absorbed and rapidly metabolised to nortilidine, bisnortilidine. 100 fold more active than Tilidine.

Amount: